Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 64

Therapeutics

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
Biotechnology | FDA | Non-Profit Research | Oncology | Therapeutics

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders

On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…

Read More The FDA approved Gleevec for Five Rare, Life-Threatening DisordersContinue

The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
Biotechnology | FDA | Therapeutics

The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis

On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…

Read More The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosisContinue

The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
Biotechnology | FDA | Oncology | Therapeutics

The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma

On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…

Read More The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinomaContinue

The UC San Diego Health System acquired the Nevada Cancer Institute
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The UC San Diego Health System acquired the Nevada Cancer Institute

On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…

Read More The UC San Diego Health System acquired the Nevada Cancer InstituteContinue

Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
Medicine | Non-Profit Research | Oncology | Therapeutics

Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF

On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…

Read More Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRFContinue

Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Therapeutics

Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute

On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…

Read More Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research InstituteContinue

Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
Biology | Biotechnology | Medicine | Non-Profit Research | Therapeutics

Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history

On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…

Read More Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year historyContinue

The UC Davis Comprehensive Cancer Center received NCI designation
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary

The UC Davis Comprehensive Cancer Center received NCI designation

In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…

Read More The UC Davis Comprehensive Cancer Center received NCI designationContinue

CALIBR, the California Institute for Biomedical Research, was founded
Biotechnology | Medical Device | Non-Profit Research | Therapeutics

CALIBR, the California Institute for Biomedical Research, was founded

In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…

Read More CALIBR, the California Institute for Biomedical Research, was foundedContinue

Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
Biotechnology | Diagnostics | Oncology | Therapeutics

Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut

In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…

Read More Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in ConnecticutContinue

Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award
Biotechnology | Therapeutics

Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award

In 2012, Samantha Lewis, a senior in the Oregon State University College of Science, won the Society for…

Read More Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring AwardContinue

The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center
Biotechnology | Genomics | Non-Profit Research | Therapeutics

The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center

In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…

Read More The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer CenterContinue

Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Oncology | Therapeutics

Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team

On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…

Read More Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream TeamContinue

Washington University’s Genome Institute received $114 million grant
Biotechnology | Genomics | Non-Profit Research | Therapeutics

Washington University’s Genome Institute received $114 million grant

On Dec. 6, 2011, Washington University’s Genome Institute received a four-year $114 million grant from the National Human…

Read More Washington University’s Genome Institute received $114 million grantContinue

The CDC activated the Emergency Operations Center to support the global polio eradication effort
Biotechnology | CDC | Infectious Disease | NIH | Non-Profit Research | Polio | Therapeutics

The CDC activated the Emergency Operations Center to support the global polio eradication effort

On Dec. 2, 2011, the U.S. Centers for Disease Control and Prevention (CDC) Director Thomas R. Frieden, MD,…

Read More The CDC activated the Emergency Operations Center to support the global polio eradication effortContinue

MUSC dedicated new bioengineering and drug discovery hubs
Biotechnology | Medical Device | Non-Profit Research | Therapeutics | U.S. Congress

MUSC dedicated new bioengineering and drug discovery hubs

On Oct. 24, 2011, the Medical University of South Carolina (MUSC) officially dedicated the James E. Clyburn Research…

Read More MUSC dedicated new bioengineering and drug discovery hubsContinue

The OHSU/OSU Collaborative Life Sciences Building broke ground
Biotechnology | Dentistry | Diagnostics | Medicine | Non-Profit Research | Therapeutics

The OHSU/OSU Collaborative Life Sciences Building broke ground

On Oct. 13, 2011, the OHSU/OSU Collaborative Life Sciences Building (CLSB) broke ground on the new $295 million…

Read More The OHSU/OSU Collaborative Life Sciences Building broke groundContinue

The CDC responded to a multi-state outbreak of listeriosis
Biotechnology | CDC | Infectious Disease | NIH | Non-Profit Research | Therapeutics

The CDC responded to a multi-state outbreak of listeriosis

On Sept. 30, 2011, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…

Read More The CDC responded to a multi-state outbreak of listeriosisContinue

Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics

Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona

On Sept. 27, 2011, the Mayo Clinic announced a $120 million plan to open its first medical school…

Read More Mayo Clinic announced plans to open a medical school in Scottsdale, ArizonaContinue

The Monroe Cancer Center opened
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

The Monroe Cancer Center opened

On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…

Read More The Monroe Cancer Center openedContinue

Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
Biotechnology | Diagnostics | Disease | Therapeutics

Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks

On Aug. 17, 2011, Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks. When…

Read More Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banksContinue

Genentech drug Zelboraf (vemurafenib) was approved
Biotechnology | FDA | Life Science History | Oncology | Therapeutics

Genentech drug Zelboraf (vemurafenib) was approved

On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…

Read More Genentech drug Zelboraf (vemurafenib) was approvedContinue

Genomeon was established under the laws of the Commonwealth of Virginia
Biotechnology | Diagnostics | Genomics | Life Science History | Medicine | Therapeutics

Genomeon was established under the laws of the Commonwealth of Virginia

On Aug. 11, 2011, Genomeon was established under the laws of the Commonwealth of Virginia by Dr. Harold…

Read More Genomeon was established under the laws of the Commonwealth of VirginiaContinue

Siteman Cancer Center performed its 5,000th bone marrow transplant
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics

Siteman Cancer Center performed its 5,000th bone marrow transplant

On Aug. 9,  2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…

Read More Siteman Cancer Center performed its 5,000th bone marrow transplantContinue

The Maine Institute for Human Genetics and Health discontinued operations
Biotechnology | Diagnostics | Disease | Therapeutics

The Maine Institute for Human Genetics and Health discontinued operations

On Jul. 17, 2011, the Maine Institute for Human Genetics and Health announced that it would cease operations…

Read More The Maine Institute for Human Genetics and Health discontinued operationsContinue

Genome for endangered Tasmanian tiger was completed
Biotechnology | Disease | Genomics | Life Science History | Oncology | Therapeutics

Genome for endangered Tasmanian tiger was completed

On Jun. 28, 2011, to prevent extinction of the Tasmanian tiger, a team of scientists led by the…

Read More Genome for endangered Tasmanian tiger was completedContinue

TomoTherapy acquired by Accuray
Biotechnology | Oncology | Radiology | Therapeutics

TomoTherapy acquired by Accuray

On Jun. 13, 2011, Accuray announced it had completed its acquisition of TomoTherapy. The combination creates the premier…

Read More TomoTherapy acquired by AccurayContinue

University Hospitals Seidman Cancer Center opened
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

University Hospitals Seidman Cancer Center opened

On Jun. 6, 2011, University Hospitals (UH) Seidman Cancer Center, Northeast Ohio’s first and only freestanding cancer hospital,…

Read More University Hospitals Seidman Cancer Center openedContinue

Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
Biotechnology | Neurology | Non-Profit Research | Therapeutics

Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine

On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…

Read More Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on NilvadipineContinue

Sandia and Cray tackled big data in new supercomputing institute
Biotechnology | Diagnostics | Energy | Genomics | Medical Device | Non-Profit Research | Therapeutics

Sandia and Cray tackled big data in new supercomputing institute

On May 20, 2011, Sandia and supercomputer manufacturer Cray Inc. announced they had signed a cooperative research and…

Read More Sandia and Cray tackled big data in new supercomputing instituteContinue

Page navigation

Previous PagePrevious 1 … 62 63 64 65 66 … 106 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search